University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

O

Status Drug name NICE TAs Comments
Status: Red Obeticholic acid (Ocaliva®)

Off label use. Consultant initiation only (gastro use). Hospital only - in line with NICE TA443.
Status: Red Obinutuzumab (Gazyvaro®)
  • For hospital use only
  • Off label use - for thrombotic thrombocytopenic purpura (TTP)
Status: Red Ocrelizumab
Status: Red Ocriplasmin (Jetrea®) injection

For hospital use only
Status: Red Octaplas®

Alternative to Factor XI when it is unavailable
Status: Amber Octasa ® 1g suppositories
Status: Green Octenisan antimicrobial wash lotion
Status: Green Octenisan nasal gel

Where allergy to Bactroban® exists or there are supply issues with Bactroban®
Status: Red Octreotide (Sandostatin LAR®) injection

Amber - palliative care use only

Red - Oncology, acromegaly
Status: Amber Octreotide injection

For gastroenterology use - initiation by specialist

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top